
Year
2012
Status
Active
Team
Field
Drug delivery technology; oncology therapeutic
Location
Maastricht (The Netherlands)
Fund
BGV II
Cristal Therapeutics
Cristal Therapeutics develops, a new class of nanomedicines based on its proprietary polymeric technologies with an optimized drug disposition and a more favorable tolerability profile.